Amneal Pharmaceuticals, Inc. AMRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2009-11-18
Amneal Pharmaceuticals, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 11,282,430 | $71.6M |
| D. E. Shaw & Co., Inc. | 1,719,954 | $21.4M |
| AQR CAPITAL MANAGEMENT LLC | 864,792 | $10.7M |
| CITADEL ADVISORS LLC | 619,419 | $7.7M |
| MILLENNIUM MANAGEMENT LLC | 419,733 | $5.2M |
| TWO SIGMA INVESTMENTS, LP | 282,677 | $3.5M |
| RENAISSANCE TECHNOLOGIES LLC | 276,637 | $3.4M |
| Point72 Asset Management, L.P. | 78,105 | $970,845 |
Source: SEC EDGAR filings · CIK 0001723128 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.